Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03139370
Title Safety and Efficacy of MAGE-A3/A6 T Cell Receptor Engineered T Cells (KITE-718) in HLA-DPB1*04:01 Positive Adults With Advanced Cancers
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Kite, A Gilead Company
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Banner MD Anderson Cancer Center Gilbert Arizona 85234 United States Details
USC/Norris Comprehensive Cancer Center Los Angeles California 90033 United States Details
UCLA Hematology/Oncology Los Angeles California 90095 United States Details
University of California Davis Comprehensive Cancer Center Sacramento California 95817 United States Details
H. Lee Moffitt Cancer and Research Institute Tampa Florida 33612 United States Details
University of Chicago Chicago Illinois 60640 United States Details
Massachusetts General Hospital Boston Massachusetts 02114 United States Details
Icahn School of Medicine at Mount Sinai New York New York 10029 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
Baylor Scott & White Charles A. Sammons Cancer Center Dallas Texas 75246 United States Details
The University of Texas MD Anderson Cancer Center Houston Texas 77030 United States Details
University of Utah, Huntsman Cancer Institute Salt Lake City Utah 84112 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field